0001209191-22-028567.txt : 20220512 0001209191-22-028567.hdr.sgml : 20220512 20220512163049 ACCESSION NUMBER: 0001209191-22-028567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220510 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aftab Blake CENTRAL INDEX KEY: 0001886986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 22918339 MAIL ADDRESS: STREET 1: C/O ADICET BIO, INC. STREET 2: 200 CLARENDON STREET, FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET STREET 2: FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET STREET 2: FLOOR 6 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-10 0 0001720580 Adicet Bio, Inc. ACET 0001886986 Aftab Blake C/O ADICET BIO, INC. 200 CLARENDON STREET, FLOOR 6 BOSTON MA 02116 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 12.18 2022-05-10 4 A 0 60000 0.00 A 2032-05-09 Common Stock 60000 60000 D 25% of the shares subject to the stock option shall vest on April 29, 2023 and, thereafter, the remainder of the shares shall vest in 36 equal monthly installments, provided that the Reporting Person maintains a service relationship with the Company as of the applicable vesting dates. /s/ Nick Harvey, Attorney-in-Fact 2022-05-12